Repligen Corp
NASDAQ:RGEN

Watchlist Manager
Repligen Corp Logo
Repligen Corp
NASDAQ:RGEN
Watchlist
Price: 166.36 USD 0.47% Market Closed
Market Cap: 9.4B USD

Wall Street
Price Targets

RGEN Price Targets Summary
Repligen Corp

Wall Street analysts forecast RGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGEN is 193.06 USD with a low forecast of 161.6 USD and a high forecast of 231 USD.

Lowest
Price Target
161.6 USD
3% Downside
Average
Price Target
193.06 USD
16% Upside
Highest
Price Target
231 USD
39% Upside
Repligen Corp Competitors:
Price Targets
EVT
Evotec SE
68% Upside
ERF
Eurofins Scientific SE
7% Upside
SAILIFE
Sai Life Sciences Ltd
21% Upside
2268
WuXi XDC Cayman Inc
18% Upside
GUBRA
Gubra A/S
23% Upside
ICLR
ICON PLC
15% Upside
TECH
Bio-Techne Corp
20% Upside
SHC
Sotera Health Co
11% Upside

Revenue
Forecast

Revenue Estimate
Repligen Corp

For the last 12 years the compound annual growth rate for Repligen Corp's revenue is 21%. The projected CAGR for the next 4 years is 16%.

21%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Repligen Corp

For the last 12 years the compound annual growth rate for Repligen Corp's operating income is 0%. The projected CAGR for the next 4 years is 112%.

0%
Past Growth
112%
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Net Income
Forecast

Net Income Estimate
Repligen Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RGEN's stock price target?
Price Target
193.06 USD

According to Wall Street analysts, the average 1-year price target for RGEN is 193.06 USD with a low forecast of 161.6 USD and a high forecast of 231 USD.

What is Repligen Corp's Revenue forecast?
Projected CAGR
16%

For the last 12 years the compound annual growth rate for Repligen Corp's revenue is 21%. The projected CAGR for the next 4 years is 16%.

What is Repligen Corp's Operating Income forecast?
Projected CAGR
112%

For the last 12 years the compound annual growth rate for Repligen Corp's operating income is 0%. The projected CAGR for the next 4 years is 112%.

Back to Top